Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
nanoparticles
Research
Tiba wins BARDA contract to develop RNAi flu therapeutics
The $749,999 contract will see Tiba Biotech build on previous work to develop new a RNAi-based therapeutic against the H1N1 strain of the swine flu.
Helen Floersh
Jul 11, 2024 3:35pm
Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
Jan 23, 2024 7:00am
Young livers may filter out nanodrugs, stifling their efficacy
Sep 25, 2023 5:30am
NexImmune halves team as cash forces focus on core capabilities
Sep 1, 2023 6:39am
Takeda, Poseida see promising data for hemophilia A gene therapy
Dec 14, 2022 3:15pm
Scientists explore 'mosaic', inhaled COVID-19 vaccine options
Jul 7, 2022 2:34pm